ASKA Pharmaceutical Holdings in Numbers

Foundation

105years

（Founded in 1920）

Female Medicine Research

100years

* Over 100 years

Ob/Gyn* field

Top share in Japan

Leading Company

※In-house estimate

Thyroid field

Top share in Japan

95%

Consolidated Sales

62.8

billion yen

（FY2023）

ASKA Pharmaceutical 56.0 billion yen
（Pharamaceutical business）
ASKA Animal Health 6.6 billion yen
（Animal health business）
ASKA Pharma Medical 0.16 billion yen
（Testing business）

Number of Employees

762

（End of FY2023）

Major business sites

23

Including 1 international site

Operating profit margin

10.3％

（FY2023）

ROE（Return on Equity）

13.0％

（FY2023）

Dividend payout ratio

30％

（Benchmark ratio）
*A minimum annual dividend per
share of 30 yen

R&D expenses

4.7
billion yen

(FY2023)
*ASKA Pharmaceutical

Promotion of Women's advancement

Ratio of female
employees^*1

32.7％

Ratio of female management positions^*2

12.4％

Ratio of female management candidates^*1

23.0％

*1 End of FY2023 in ASKA Pharmaceutical
*2 As of September 30, 2024 in ASKA Pharmaceutical

Initiatives to Promote the Advancement of Women

Ratio of male employees taking child care leave

100.0％

（FY2023 in ASKA Pharmaceutical)

Initiatives to Promote the Advancement of Women

Reduction rate of Total CO₂ Emissions

49.2％

* The rate in FY2023 compared with the rate in FY2013

Decarbonization Initiatives